In another study, antibodies against the GluN1-S2 subunit of the NMDA receptor were found in the serum of 44% of 48 stroke patients compared to 3% in age matched healthy controls within 48 h of stroke onset. This evidence concerns the gene GRIN1 and stroke disorder.